ILUVIEN Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema

Alimera Sciences announced the Austrian Agency for Health and Food Safety has granted marketing authorization to its drug ILUVIEN for the treatment of diabetic macular edema, following recommendation for approval of the drug's use in Europe.... [more]

View complete Yahoo Finance article